BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BudMaps - ECPv6.0.13.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://budmaps.com.br/en
X-WR-CALDESC:Eventos para BudMaps
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Sao_Paulo
BEGIN:STANDARD
TZOFFSETFROM:-0200
TZOFFSETTO:-0300
TZNAME:-03
DTSTART:20170219T020000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0300
TZOFFSETTO:-0200
TZNAME:-02
DTSTART:20171015T030000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20171001T160000
DTEND;TZID=America/Sao_Paulo:20171001T180000
DTSTAMP:20260429T231433
CREATED:20170918T125400Z
LAST-MODIFIED:20170918T125400Z
UID:99994283-1506873600-1506880800@budmaps.com.br
SUMMARY:Reunião da Marcha - Organização do Novembro Verde (II)
DESCRIPTION:Reunião da Marcha da Maconha Curitiba para organizar as atividades do “Novembro Verde” (conjunto de ações relativas à legalização da Maconha Medicinal). \nReunião será no 2º andar do Villa Bambu e terá início pontualmente no horário divulgado. \nTodos interessados são bem vindos! Procurem a galera com camiseta da Marcha da Maconha e se apresentem! Estamos sempre abertos a novos membros!!! 😉
URL:https://budmaps.com.br/en/evento/reuniao-da-marcha-organizacao-do-novembro-verde-ii/
ATTACH;FMTTYPE=image/jpeg:https://budmaps.com.br/wp-content/uploads/facebook_event_264681920711505.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20171007T230000
DTEND;TZID=America/Sao_Paulo:20171008T035900
DTSTAMP:20260429T231433
CREATED:20170915T175757Z
LAST-MODIFIED:20170915T175757Z
UID:99994279-1507417200-1507435140@budmaps.com.br
SUMMARY:Legalizing Psychedelic Medicine
DESCRIPTION:You are invited to an evening soirée in Soho\, New York.  \nJoin the company of like-minded individuals\, share your perspective among other trailblazers\, enjoy a psychedelic comedy performance\, and show your support for the legalization of psychedelic medicine. \nSaturday\, October 7\, 2017\nDoors open at 7:00 P.M.\nFood served at 7:30 P.M.\nProgram begins at 9:00 P.M. \nSpeakers: \nMAPS Founder and Executive Director\, Rick Doblin\, Ph.D.\, will host an illuminating conversation about how the path to legalizing psychedelic medicine leads to his vision of a post-prohibition world; where psychedelics are used as prescription medicines\, as valuable tools for inspiring creativity\, for personal and spiritual growth\, and for catalyzing resolutions to global and social conflicts. \nAuthor Rachel Hope overcame treatment-resistant PTSD after participating in MAPS’ Phase 2 clinical research. Rachel is now a public advocate for the legalization of this potentially life-saving therapy. \nShannon Clare Carlin\, M.A.\, is investigating MDMA-assisted psychotherapy for PTSD as a co-therapist at the Phase 3 study site in Los Angeles\, California. Shannon previously treated Phase 2 study participants for anxiety associated with life-threatening illness. Shannon serves as Therapy Training Program Manager\, and oversees education for therapists. \nComedian Adam Strauss’ work has been called many things\, mostly adjectives. The New York Times said The Mushroom Cure\, Adam’s true account of his attempt to treat his severe OCD with psychedelics\, “mines a great deal of laughter from disabling pain.” Time Out New York called it “riveting… a true-life tour de force” and named it a Critics’ Pick. \nBreakthrough Therapy Designation \nPreliminary studies have shown that MDMA combined with psychotherapy can help people overcome PTSD. After careful review of these studies\, the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of PTSD. By granting Breakthrough Therapy Designation\, the FDA has agreed that this treatment may have a meaningful advantage and greater compliance over available medications for PTSD. Breakthrough Therapy Designation also means that the FDA will work closely with MAPS to complete Phase 3 trials\, the final phase of research\, as efficiently as possible. \nPhase 3 trials require more clinical sites\, more therapists\, more patients\, and more support.  This research is crucial to receiving government approval of MDMA-assisted psychotherapy as a legal treatment\, which would radically shift policy and public perception surrounding psychedelics. \nHealing Trauma \nTogether\, we can work to heal millions of people suffering from PTSD by supporting groundbreaking research into psychedelic therapies. This research is essential to obtaining government approval of MDMA-assisted psychotherapy as a legal treatment\, which would radically shift policy and public perception surrounding psychedelics. There is a need unmet by modern psychiatry and psychotherapy that psychedelic-assisted therapies can fill. \nWe can create this future together. Join us in opening the doors to new models for healing and personal growth. Proceeds from the event benefit MAPS’ research and education programs. The first $20\,000 donated on-site will be matched 2:1 by generous donors Laura and Ed Littlefield who pledged $40\,000. \nSpecial thanks to our hosts\, Giancarlo and Stephanie Canavesio\, and to host committee members Susan Brody\, Sheila Burgel\, Sir Ivan\, Joshua Mailman and Monica Winsor\, John McCormick\, Stefanie Frank\, Rodrigo Nino\, Daniel Pinchbeck\, Carey and Claudia Turnbull. Additional members to be announced. \nThis event coincides with the Horizons 2017: Perspectives on Psychedelics conference taking place in New York\, New York\, from October 6-8\, 2017. \nmaps.org/nyc2017 \nFor more information\, contact the MAPS office at (831) 429-6362 or events@maps.org. \nLearn about our research and other events at maps.org
URL:https://budmaps.com.br/en/evento/legalizing-psychedelic-medicine/
ATTACH;FMTTYPE=image/jpeg:https://budmaps.com.br/wp-content/uploads/facebook_event_353136551795571.jpg
END:VEVENT
END:VCALENDAR